Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

2.70
Delayed Data
As of Aug 03
 0.00 / 0.00%
Today’s Change
2.08
Today|||52-Week Range
5.42
-1.46%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close2.70
Today’s openn.a.
Day’s range2.65 - 2.84
Volume8,268
Average volume (3 months)864,615
Market cap$180.6M
Dividend yield--
Data as of 08/03/2015

Growth & Valuation

Earnings growth (last year)+61.81%
Earnings growth (this year)-107.27%
Earnings growth (next 5 years)--
Revenue growth (last year)-66.67%
P/E ratioNM
Price/Sales1,489.77
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd0.000.00%
ASTAsterias Biotherapeu...-0.06-1.22%
SZYMSolazyme Inc0.000.00%
PSTIPluristem Therapeuti...-0.06-2.51%
Data as of 4:01pm ET, 08/03/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$100.0K
Annual profit (last year)-$30.1M
Net profit margin-30,117.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts